F2G
1 follower
‌
F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections.
Industries
Headquarters
Employees
Links
Org chart
Francesco Maria Lavino
Collapse
Ralf Schmid
CFO
John H. Rex
Chief Medical Officer
Mike Birch
COO
Tony Kennedy
Chief Scientific & Development Officer
Janelle R. Anderson
Chief Business Officer
Mark Baglin
Chief Commercial Officer
Ana Zaccaro
Vice President Regulatory Affairs
daniela zinzi
VP, Clinical R&D
Dean Thompson
Director, Analytical Development
Mark Bresnik, MD
Executive Director, Clinical R&D
Karen Cornelissen
Director Early Clinical Development
Sufyaan Bhamjee
In-House Counsel
Similar companies
Oxford Quantum Circuits
2 followers
REVOLUTION Medicines
5 followers
Bolt Biotherapeutics
5 followers
Stemline Therapeutics
3 followers
Freenome
3 followers
Dyne Therapeutics
3 followers
Mammoth Biosciences
3 followers
AC Immune
2 followers
Arcutis Biotherapeutics
2 followers
Autolus
1 follower
Vividion Therapeutics
1 follower
Discover companies